Kevin T. Schultz

1.2k total citations
45 papers, 867 citations indexed

About

Kevin T. Schultz is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Epidemiology. According to data from OpenAlex, Kevin T. Schultz has authored 45 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Ecology, Evolution, Behavior and Systematics and 10 papers in Epidemiology. Recurrent topics in Kevin T. Schultz's work include Vector-Borne Animal Diseases (11 papers), Viral Infections and Vectors (10 papers) and HIV Research and Treatment (7 papers). Kevin T. Schultz is often cited by papers focused on Vector-Borne Animal Diseases (11 papers), Viral Infections and Vectors (10 papers) and HIV Research and Treatment (7 papers). Kevin T. Schultz collaborates with scholars based in United States, Russia and Australia. Kevin T. Schultz's co-authors include Thomas M. Yuill, Douglas J. DeBoer, George V. Ludwig, Bruce M. Christensen, Franziska B. Grieder, C. David Pauza, Parul Trivedi, Peter Emau, Miroslav Malkovský and María S. Salvato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Kevin T. Schultz

45 papers receiving 831 citations

Peers

Kevin T. Schultz
Franziska B. Grieder United States
Rebecca Gray United States
DANNY L. WIEDBRAUK United States
Melinda S. Camus United States
Liam Brierley United Kingdom
Ha Youn Lee United States
Franziska B. Grieder United States
Kevin T. Schultz
Citations per year, relative to Kevin T. Schultz Kevin T. Schultz (= 1×) peers Franziska B. Grieder

Countries citing papers authored by Kevin T. Schultz

Since Specialization
Citations

This map shows the geographic impact of Kevin T. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin T. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin T. Schultz more than expected).

Fields of papers citing papers by Kevin T. Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin T. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin T. Schultz. The network helps show where Kevin T. Schultz may publish in the future.

Co-authorship network of co-authors of Kevin T. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin T. Schultz. A scholar is included among the top collaborators of Kevin T. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin T. Schultz. Kevin T. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinet, Julie, Kevin T. Schultz, Paul J. May, & Paul D. Gamlin. (2020). Neural control of rapid binocular eye movements: Saccade-vergence burst neurons. Proceedings of the National Academy of Sciences. 117(46). 29123–29132. 23 indexed citations
2.
Pavlicek, Rebecca L., Simon O. Owino, Kaori Sakamoto, et al.. (2018). Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs. Tuberculosis. 113. 179–188. 5 indexed citations
3.
Schultz, Kevin T., et al.. (2000). Identification and Localization of Conserved Antigenic Epitopes on the G2 Proteins of California Serogroup Bunyaviruses. Viral Immunology. 13(2). 201–213. 3 indexed citations
4.
Rodas, Juan David, et al.. (1999). Potential for evolution of California serogroup bunyaviruses by genome reassortment in Aedes albopictus.. American Journal of Tropical Medicine and Hygiene. 60(3). 430–438. 25 indexed citations
5.
Israel, Barbara A., Kevin T. Schultz, & Christopher J. Murphy. (1998). Lack of Detectable Interaction between HSV-1 and Integrins or Tachykinins. Intervirology. 41(2-3). 132–134. 5 indexed citations
6.
Bernard, Kathryn, Barbara A. Israel, & Kevin T. Schultz. (1996). A Complex Neutralization Domain of Bluetongue Virus Serotype 17 Defines a Virulence-Associated Marker. Viral Immunology. 9(2). 97–106. 5 indexed citations
7.
Israel, Barbara A., et al.. (1995). An analysis of co-circulating serotypes for bluetongue-17 virulence markers. Microbial Pathogenesis. 18(5). 337–344. 1 indexed citations
8.
Salvato, María S., Peter Emau, Miroslav Malkovský, et al.. (1994). Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. Journal of Medical Primatology. 23(2-3). 125–130. 33 indexed citations
9.
Golos, Thaddeus G., et al.. (1994). Primary cultures of rhesus placental syncytiotrophoblasts are permissive for SIV infection. Journal of Medical Primatology. 23(2-3). 66–74. 5 indexed citations
10.
Tomar, Russell H., et al.. (1992). Sera from simian immunodeficiency virus‐infected rhesus macaques inhibit lymphocyte proliferation. Journal of Clinical Laboratory Analysis. 6(5). 297–301. 1 indexed citations
11.
Longhofer, Susan L., et al.. (1991). Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis. American Journal of Veterinary Research. 52(3). 480–487. 9 indexed citations
12.
Lairmore, Michael D., et al.. (1990). SIV, STLV-I, and Type D Retrovirus Antibodies in Captive Rhesus Macaques and Immunoblot Reactivity to SIV p27 in Human and Rhesus Monkey Sera. AIDS Research and Human Retroviruses. 6(11). 1233–1238. 20 indexed citations
13.
DeBoer, Douglas J., Karen A. Moriello, Chester B. Thomas, & Kevin T. Schultz. (1990). Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs. American Journal of Veterinary Research. 51(4). 636–639. 25 indexed citations
14.
Schultz, Kevin T., et al.. (1990). Antigenic topography of bluetongue virus 17. Microbial Pathogenesis. 8(4). 299–303. 5 indexed citations
15.
Grieder, Franziska B. & Kevin T. Schultz. (1990). Antiidiotypic antibody mimicry of a bluetongue virus neutralizing antigen.. The Journal of Immunology. 144(7). 2627–2631. 14 indexed citations
16.
Longhofer, Susan L., et al.. (1990). Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs. American Journal of Veterinary Research. 51(11). 1746–1750. 2 indexed citations
17.
Grieder, Franziska B. & Kevin T. Schultz. (1989). Conformationally Dependent Epitopes of Bluetongue Virus Neutralizing Antigen. Viral Immunology. 2(1). 17–24. 9 indexed citations
18.
Schultz, Kevin T., et al.. (1989). ELISA for Detection of Antibodies to a Type D Retrovirus, SRV-W. Viral Immunology. 2(1). 47–55. 4 indexed citations
19.
Ludwig, George V., Bruce M. Christensen, Thomas M. Yuill, & Kevin T. Schultz. (1989). Enzyme processing of La Crosse virus glycoprotein G1: A bunyavirus-vector infection model. Virology. 171(1). 108–113. 48 indexed citations
20.
Schultz, Kevin T.. (1982). Type I and type IV hypersensitivity in animals. Journal of the American Veterinary Medical Association. 181(10). 1083–1087. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026